JY
KITE

Jeff Yass’s Kite Pharma, Inc. KITE Stock Holding History

Jeff Yass’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-431,700
Closed -$77.6M – 10414
2017
Q3 		$77.6M Buy
431,700
+219,000
+103% +$30.5M 0.03% 479
2017
Q2 		$22.1M Sell
212,700
-1,300
-0.6% -$106K 0.01% 1094
2017
Q1 		$16.8M Buy
214,000
+60,700
+40% +$3.75M 0.01% 1208
2016
Q4 		$6.87M Sell
153,300
-122,500
-44% -$6.01M ﹤0.01% 1983
2016
Q3 		$15.4M Sell
275,800
-112,200
-29% -$6.25M 0.01% 1204
2016
Q2 		$19.4M Buy
388,000
+149,100
+62% +$7.33M 0.01% 1000
2016
Q1 		$11M Buy
238,900
+148,600
+165% +$7.2M 0.01% 1465
2015
Q4 		$5.56M Sell
90,300
-205,800
-70% -$14.5M ﹤0.01% 2397
2015
Q3 		$16.5M Buy
296,100
+151,900
+105% +$9.55M 0.01% 1391
2015
Q2 		$8.79M Buy
144,200
+31,200
+28% +$1.78M ﹤0.01% 2155
2015
Q1 		$6.52M Buy
113,000
+67,800
+150% +$4.54M ﹤0.01% 2376
2014
Q4 		$2.61M Buy
+45,200
New +$1.9M ﹤0.01% 3961

Jeff Yass's KITE Position: Q4 2017 in Review

Jeff Yass sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 158,135 shares — an estimated $28.4M sold.

Jeff Yass first reported a position in KITE in Q4 2014 and held it in 11 quarters. The position peaked at $29.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Jeff Yass reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Jeff Yass sold 158,135 Kite Pharma, Inc. shares in Q4 2017, an estimated $28.4M.
  • Jeff Yass first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 11 quarters.
  • Jeff Yass's Kite Pharma, Inc. position peaked at $29.8M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.